Qiang Li's Publications
About Qiang Li's Publications
Senior Biostatistician-
RESTING HEART RATE AND THE RISK OF DEATH AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Journal of Hypertension Date published: -
Determinants of Quality of Life After Stroke in China
Stroke Date published: -
Is low HDL cholesterol a risk factor for the microvascular disease of diabetes? Results from the ADVANCE study
Date published: -
DEFINING NORMAL: QUALITATIVE DESCRIPTIONS OF FETAL MOVEMENT IN A NORMAL HEALTHY PREGNANT POPULATION
Date published: -
Regulation of Secretion and Expression of Adiponectin by Insulin and β-Agonists in Rat
Date published: -
HDL Cholesterol is a Risk Factor for Diabetic Nephropathy But Not Retinopathy�Results From the ADVANCE Study
Heart, Lung and Circulation Date published: -
Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes
Journal of the American College of Cardiology Date published: -
Severe Hypoglycemia and Risks of Vascular Events and Death
New England Journal of Medicine Date published: -
Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis
Intensive Care Medicine Date published: -
Age and Gender Variations in the Management of Ischaemic Stroke in China
International Journal of Stroke Date published: -
Nature of association between severe hypoglycaemia and risks of vascular events and death in ADVANCE
Date published: -
Short Sleep Duration in Prevalent and Persistent Psychological Distress in Young Adults: The DRIVE Study
Sleep Date published: -
Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial
Diabetologia Date published: -
Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage
Stroke Date published: -
Patterns of use of glucose lowering treatments at baseline and during follow-up in ADVANCE
Date published: -
Intensive glucose control is renoprotective in type 2 diabetes: New analyses from ADVANCE
Date published: